Section 1 definition of "Act" BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
"Act" means the Emergency and Health Services Act;
Section 1 definition of "Rules" BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
"rules" means the rules made under section 14 (5) of the Act.
Section 2 (c) (ii) BEFORE amended by BC Reg 62/2011, effective April 1, 2011.
(ii) has passed the examinations approved by the board for the category, and
Section 2 BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
Application for licence
2 The board may issue a licence in a category to a person who
(a) is not licensed as an EMA in the category,
(b) applies, in the form and manner approved by the board, for a licence in the category, and
(c) provides evidence, satisfactory to the board, that the person
(i) has successfully completed the training program or programs recognized by the board for the category,
(ii) has, no later than 12 months after the date the person completed the training program or programs referred to in subparagraph (i), passed the examinations approved by the board for the category, and
(iii) is of good character and fit to work as an EMA.
[am. B.C. Reg. 62/2011, s. 1.]
Section 2 was renumbered as 2 (1) by BC Reg 194/2022, effective September 28, 2022.
Section 2 (1) (c) (ii)BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(ii) has, no later than 12 months after the date the person completed the training program or programs referred to in subparagraph (i), passed the examinations approved by the licensing board for the category, and
Section 2 (2) was added by BC Reg 194/2022, effective September 28, 2022.
Section 3 (2) and (3) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(2) The board may issue a licence in a category to a person who
(a) is not licensed as an EMA,
(b) applies to the registrar, in the form and manner approved by the board, for a licence in the category, and
(c) provides evidence, satisfactory to the board, that the person
(i) has in another jurisdiction an authorization to practise that is, in the opinion of the board, equivalent to an authorization to practise as an EMA in the category,
(ii) is in good standing in that other jurisdiction, and
(iii) is of good character and fit to work as an EMA.
(3) If subsection (2) would apply except for the fact that the board does not consider that the qualifications, examinations or training required for the applicant's authorization to practise in the other jurisdiction are equivalent to those required in British Columbia for the category of licence sought, the board
(a) may require the applicant, before the application is approved and a licence is issued, to successfully complete the examinations or training programs that the board considers necessary or appropriate, and
(b) in choosing examinations or training programs for the purpose of paragraph (a), must cover only matters for which the examinations or training of the other jurisdiction are not considered by the board to be equivalent to those required in British Columbia for the category.
Section 4 BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
Short term licence for non-students
4 (1) In this section, "applicant" means an applicant for a licence in a category
(a) under section 2 who has successfully completed the training programs recognized by the board for the category, or
(b) under section 3.
(2) If the board is of the opinion that an applicant, although not currently qualified, is likely to qualify to be licensed in the category applied for within the near future, the board may
(a) issue to the applicant a licence in that category for a period of up to 30 days, and
(b) extend the term of the licence issued under paragraph (a) for a period of up to 30 days on one or more occasions,
but the total period of the licence must not exceed one year.
(3) If the board issues a licence under this section, it may defer the decision to act or not act under section 2 or 3 during the term of the licence.
(4) If the applicant is an applicant under section 3, section 3 (3) (b) applies to any examinations or training programs that the board requires the applicant to take as a term or condition of a licence issued under this section.
Section 5 BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
Short term licence for students
5 (1) In this section, "applicant" means an applicant, under section 2, for a licence in a category who has not completed the training programs recognized by the board for the category.
(2) If the board is of the opinion that an applicant, although not currently qualified, is likely to qualify to be licensed under section 2 in the category applied for within the period, the board may issue to the applicant a licence in that category for a period of up to a year.
(3) If the board is of the opinion that an applicant is likely to qualify to be licensed under section 2 in the category within the period of the extension, the board may extend the term of a licence issued under this section for a period of up to 180 days on one or more occasions, but the total period of the licence including the period under subsection (2) must not exceed 2 years.
(4) If the board issues a licence under this section, it may defer the decision to act or not act under section 2 during the term of the licence.
Section 6 (2) to (7) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(2) If the commission determines that it is necessary or appropriate in the circumstances for the protection of public health or safety, the commission may request that the board issue a licence to a person.
(3) If the commission makes a request under subsection (2), despite sections 2 and 8 (1), the board must issue a licence in a category to the person if the board is of the opinion that the person is able to practise as an EMA in the category without unacceptable risk to public health or safety.
(4) The board may, under this section, issue a licence in a category only to a person who
(a) is an operational manager with the British Columbia Ambulance Service and has previously
(i) been licensed as an EMA, or
(ii) had an authorization in another jurisdiction to practise that is, in the opinion of the board, equivalent to an authorization to practise as an EMA,
(b) has an authorization in another jurisdiction to practise that is, in the opinion of the board, equivalent to an authorization to practise as an EMA, and is in good standing in that other jurisdiction,
(c) is a student licensed under section 5 in the category of PCP, ACP or CCP, or
(d) is a person who provides evidence, satisfactory to the board, that the person has successfully completed training programs that are, in the opinion of the board, substantially equivalent to those recognized by the board for the category.
(5) To be licensed under this section, a person must provide evidence satisfactory to the board that the person is of good character and fit to work as an EMA.
(6) If the requirements under subsections (2) and (3) continue to be met, the board may
(a) issue a licence under this section for a period of up to 30 days, and
(b) extend the term for a further period of up to 30 days on one or more occasions,
but the total period of the licence must not exceed 60 days.
(7) If the board issues a temporary licence to a student under this section,
(a) the licence held by the student under section 5 is suspended for the term of the temporary licence, and
(b) the time during which the licence under section 5 is suspended does not count in the reckoning of
(i) the term of the licence as described in section 5 (2),
(ii) any period of extension of the term, as described in section 5 (3), or
(iii) the total period of the licence, as referred to in section 5 (3),
as applicable.
Section 6 (2) and (3) BEFORE amended by BC Reg 194/2013, effective July 17, 2013.
(2) If the commission determines that it is necessary or appropriate in the circumstances for the protection of public health or safety, the commission may request that the licensing board issue a licence to a person.
(3) If the commission makes a request under subsection (2), despite sections 2 and 8 (1), the licensing board must issue a licence in a category to the person if the licensing board is of the opinion that the person is able to practise as an EMA in the category without unacceptable risk to public health or safety.
Section 7 (1) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(1) The board may issue a licence collectively recognizing as emergency medical assistants all persons certified under chapters 18.71 and 18.73 of the Revised Code of Washington of Washington State, one of the United States of America, to provide the emergency health services described in subsection (2).
Section 9 (2) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(2) The board may, prior to the date that an EMA's licence expires, extend the EMA's licence for a period not longer than 60 days, if satisfied that special circumstances exist such that the EMA will be unable, before the licence expires, to complete any requirement necessary for the renewal of the EMA's licence.
Section 9.2 BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
Reinstatement of expired licence
9.2 The board may reinstate the licence of a former EMA whose licence has expired if
(a) the board is of the opinion that reinstatement would not constitute an undue risk to public health or safety, and
(b) the former EMA successfully completes any training or written, oral or practical examinations required by the board for the purpose of this section.
[en. B.C. Reg. 62/2011, s. 3.]
Section 10 (1) and (2) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(1) If an EMA provides evidence, satisfactory to the board, that the EMA has passed the examinations approved by the board for the purposes of this subsection, the board may endorse a licence to permit the EMA to provide a service specified in Schedule 2 for the category of licence in which the EMA is licensed.
(2) If the commission has approved a research project related to the provision of emergency health services, the board may, on request of the commission, endorse a licence to permit an EMA to provide a service described in the research project.
Section 10 (2) BEFORE amended by BC Reg 194/2013, effective July 17, 2013.
(2) If the commission has approved a research project related to the provision of emergency health services, the licensing board may, on request of the commission, endorse a licence to permit an EMA to provide a service described in the research project.
Section 10 (1) BEFORE amended by BC Reg 76/2014, effective May 1, 2014.
(1) If an EMA provides evidence, satisfactory to the licensing board, that the EMA has passed the examinations approved by the licensing board for the purposes of this subsection, the licensing board may endorse a licence to permit the EMA to provide a service specified in Schedule 2 for the category of licence in which the EMA is licensed.
Section 10 (4) to (7) BEFORE repealed by BC Reg 239/2016, effective October 14, 2016.
(4) If the corporation determines that it is necessary or appropriate in the circumstances for the protection of public health or safety, the corporation may request that the licensing board endorse the licence of a person who holds a licence in the category EMA FR or EMR to permit the person to dispense and administer narcotic antagonist drugs.
(5) If the corporation makes a request under subsection (4), despite subsection (1), the licensing board must endorse the licence as requested.
(6) An endorsement under subsection (5) is subject to the condition that a narcotic antagonist drug must not be dispensed or administered to an individual except in accordance with the direction of a medical practitioner who is an employee or agent of the corporation.
(7) Despite section 2 (3) of the Drug Schedules Regulation, a narcotic antagonist drug listed in Schedule I of that regulation may be provided to the public by a person whose licence is endorsed under subsection (5) of this section.
Section 13 (1) (c) and (e) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(c) any terms, limits or conditions set or imposed by the board for the licence;
(e) any other information the board considers necessary or appropriate.
Section 13 (2) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(2) An EMA must notify the board, in writing, of any change of name, address or place of employment within 30 days after the change, and the change must be entered in the register.
Section 14 (1) and (2) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(1) The register and rules must be open to inspection at the office of the board by any person, free of charge, during regular business hours.
(2) Despite subsection (1), the board may refuse access by a person to the register if it is reasonable to believe that
(a) the access could threaten the safety of an EMA, or
(b) the person seeking access is doing so for commercial purposes.
Section 14 BEFORE re-enacted by BC Reg 243/2024, effective July 23, 2024.
Inspection of register
14 (1) The register and rules must be open to inspection at the office of the licensing board by any person, free of charge, during regular business hours.
(2) Despite subsection (1), the licensing board may refuse access by a person to the register if it is reasonable to believe that
(a) the access could threaten the safety of an EMA, or
(b) the person seeking access is doing so for commercial purposes.
(3) If access is refused under subsection (2), information appropriate in the circumstances concerning matters recorded in the registry may be disclosed, in lieu of access, to the person refused access.
[am. B.C. Reg. 144/2013, Sch. 2, s. 1 (b).]
Section 15 definition of "IV start" BEFORE repealed by BC Reg 288/2012, effective September 27, 2012.
"IV start" means a successful initiation of a peripheral intravenous line;
Section 15 definition of "reporting period" BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
"reporting period" means
(a) in respect of a continuing education credit or patient contact, the period from April 1 of each year to March 31 of the following year, and
(b) in respect of an IV start, the period from January 1 to December 31 in each year.
Section 18 BEFORE repealed by BC Reg 288/2012, effective September 27, 2012.
Continuing competence required to maintain IV start endorsement
18 (1) An EMA holding a licence in the PCP category that is endorsed under section 10 (1) to permit the EMA to initiate peripheral intravenous lines must complete the following to the director's satisfaction:
(a) at least 15 IV starts in each of the 5 consecutive reporting periods following the reporting period in which that EMA's licence is so endorsed;
(b) at least 3 IV starts in each reporting period following the 5 consecutive reporting periods referred to in paragraph (a).
(2) An IV start will be considered to have met the requirements under subsection (1) only if the director is satisfied that the IV start was for a patient.
[en. B.C. Reg. 62/2011, s. 5.]
Section 19 (2) and (3) (part) BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
(2) If an EMA successfully completes a written examination required under section 26 (1), sections 17, 18 and 20 do not apply to the EMA in respect of the reporting period for which the examination is written.
(3) If an EMA successfully completes a practical examination required under section 26 (3), sections 17, 18 and 20 do not apply to the EMA in respect of
Section 20 BEFORE re-enacted by BC Reg 288/2012, effective September 27, 2012.
Reporting requirements
20 An EMA must,
(a) no later than April 30 in each year, beginning April 30, 2012, submit to the director the information described in section 21 (1) and (2) respecting the continuing education credits and patient contacts claimed by the EMA for the reporting period that has just ended, and
(b) no later than January 31 in each year, beginning January 31, 2012, submit to the director the information described in section 21 (3) respecting the IV starts claimed by the EMA for the reporting period that has just ended.
[en. B.C. Reg. 62/2011, s. 5.]
Section 21 (3) BEFORE repealed by BC Reg 288/2012, effective September 27, 2012.
(3) For each IV start claimed, the EMA must submit information, satisfactory to the director, respecting the following:
(a) the date and location of the IV start;
(b) the type of IV start;
(c) the number of attempts made to initiate the intravenous line;
(d) the size of the intravenous catheter.
Section 22 (b) BEFORE repealed by BC Reg 288/2012, effective September 27, 2012.
(b) under section 21 (3) may be submitted only by email, facsimile, registered mail or ordinary mail.
Section 23 (1) BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
(1) An EMA must retain, during each reporting period and for at least 3 years after the last day of each reporting period and to the satisfaction of the director, adequate supporting documentation respecting all continuing education credits, patient contacts and IV starts submitted by the EMA under section 20 for the reporting period.
Section 24 (1) and (2) BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
(1) The director may deliver a notice under this section to an EMA who the director believes has failed to meet the requirements of section 17 or 18 for the applicable reporting period, setting out the following:
(a) the reasons the director believes the EMA has failed to meet the requirements of section 17 or 18 for the reporting period;
(b) information describing the adjudication process available under section 25.
(2) A notice under subsection (1) may be delivered only
(a) after April 30 in each year, in respect of a reporting period for continuing education credits and patient contacts, and
(b) after January 31 in each year, in respect of a reporting period for IV starts.
Section 24 (3) and (4) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(3) A notice under subsection (1) must be delivered to an EMA by registered mail to the last known address of the EMA, and is deemed to have been received by the EMA 7 days after the date on which it was mailed.
(4) For the purpose of proving deemed receipt of a notice referred to in subsection (2), proof of receipt may be made by affidavit of the director as to the date on which the notice was sent by registered mail.
Section 25 (1) BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
(1) An EMA to whom a notice under section 24 is delivered may deliver to the director a request for adjudication, setting out the EMA's reasons for believing he or she has met the requirements under section 17 or 18 for the applicable reporting period.
Section 25 (5) (a) and (b) BEFORE amended by BC Reg 288/2012, effective September 27, 2012.
(a) if the director believes the EMA has met the requirements of section 17 or 18 for the applicable reporting period, deliver a notice to the EMA confirming that belief on the basis of the information available to the director at the time, and
(b) if the director continues to believe the EMA has failed to meet the requirements of section 17 or 18 for the applicable reporting period, deliver a notice to the EMA, setting out the director's reasons for continuing to believe the EMA has failed to meet those requirements for that reporting period.
Section 25 (1) BEFORE amended by BC Reg 27/2022, effective February 14, 2022.
(1) An EMA to whom a notice under section 24 is delivered may deliver to the director a request for adjudication, setting out the EMA's reasons for believing he or she has met the requirements under section 17 for the applicable reporting period.
Section 26 (5) (a) and (b) BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
(a) the director is not a delegate of the board, the director must recommend to the board and the board must consider, or
(b) the director is a delegate of the board, the director must consider
Section 27 BEFORE repealed by BC Reg 210/2010, effective October 1, 2012.
Transition
27 (1) In this section, "assessor" means a person designated by the minister to assess the professional performance of EMAs in accordance with this section.
(2) The director may establish a roster of assessors for the purposes of this section.
(3) The director may
(a) require any EMA who holds a licence on April 1, 2011 to undergo an assessment of his or her professional performance in accordance with this section if the director is of the opinion that it is necessary, in the interests of public health and safety, to do so, and
(b) assign an assessor from the roster to conduct the assessment.
(4) An EMA who is required to undergo an assessment under subsection (3) may, by delivering a notice to the director prior to the commencement of the assessment, elect to attempt a practical examination approved by the director for the purpose of this subsection.
(5) If an EMA successfully completes an examination referred to in subsection (4) on the first attempt and no later than the date specified by the director, the assessment is considered to be concluded and no further action may be taken under this section in respect of the EMA.
(6) If an EMA fails to successfully complete an examination referred to in subsection (4) on the first attempt and no later than the date specified by the director, the assessment must proceed in accordance with this section.
(7) An assessor may do any or all of the following, subject to any limits or conditions imposed on the assessor by the director:
(a) review the practice history of the EMA from April 1, 2008 to March 31, 2012, which review may include, without limitation, inspection of
(i) the records, including patient records, of the EMA that are related to the EMA's professional performance, continuing education activities, continuing education credits, patient contacts or IV starts, and
(ii) the records of the board or the ministry related to the EMA
for the reporting periods under review;
(b) require the EMA to attempt one or more written, oral or practical examinations approved by the director.
(8) An EMA who is undergoing an assessment
(a) must comply with the directions or requirements of an assessor given or imposed under subsection (7), and
(b) must not knowingly provide false information to the assessor or otherwise obstruct the assessor in the assessor's lawful performance of his or her duties or exercise of his or her powers under this section.
(9) If an EMA is required to undergo an assessment under subsection (3) and
(a) the director is not a delegate of the board, the director must recommend to the board and the board must consider, or
(b) the director is a delegate of the board, the director must consider
whether to set terms and conditions under section 6 (5) (b) of the Act for the EMA's licence, pending the completion of the review under subsection (13), with respect to the practice of the profession by or the continuing competence of the EMA.
(10) An assessor must submit to the director, in the time and manner required by the director, a written report in respect of the assessment of the EMA's professional performance.
(11) If an assessor concludes after assessing an EMA's professional performance that there is a deficiency in the EMA's knowledge, skills or abilities, the assessor may recommend in his or her report under subsection (10) that the EMA do any of the following that the assessor considers will assist the EMA to remedy the deficiency:
(a) undertake further education or training;
(b) undergo clinical or other examinations;
(c) undertake other remedial activities.
(12) An assessor must, before submitting his or her report under subsection (10), provide to the EMA an opportunity to make written submissions about the EMA's practice history and any proposed recommendations under subsection (11).
(13) The director must review a report submitted under subsection (10), and
(a) if the director is not a delegate of the board, the director must recommend to the board and the board must consider, or
(b) if the director is a delegate of the board, the director must consider
whether to set terms and conditions for the EMA's licence under section 6 (5) (b) of the Act with respect to the practice of the profession by or the continuing competence of the EMA.
(14) The director may require an EMA to undergo an assessment under subsection (3) on one occasion only.
(15) The director must not give a continuing education credit in respect of an examination taken under this section.
(16) This section is repealed on October 1, 2012, unless repealed on an earlier date.
[en. B.C. Reg. 62/2011, s. 5.]
Schedule 1, section 3 (b) (v) and (vi), and (d) were added by BC Reg 76/2014, effective May 1, 2014.
(b) electrocardiogram rhythm interpretation, cardioversion, external pacing and manual defibrillation;
(c) initiation and maintenance of intraosseous needle cannulation;
(e) maintenance of intravenous routes using intermittent infusion devices, including IV pumps;
Schedule 1, section 4 (b) BEFORE amended by BC Reg 76/2014, effective May 1, 2014.
(b) electrocardiogram rhythm interpretation, cardioversion, external pacing and manual defibrillation;
Schedule 1, section 4 (d) and (e) BEFORE repealed by BC Reg 76/2014, effective May 1, 2014.
(e) maintenance of intravenous routes using intermittent infusion devices, including IV pumps;
Schedule 1, section 5 BEFORE amended by BC Reg 76/2014, effective May 1, 2014.
CCP
5 An EMA holding a licence in the category CPP may provide the services specified in this Schedule and Schedule 2 for the category of ACP.
Schedule 1, section 6 (e) BEFORE repealed by BC Reg 76/2014, effective May 1, 2014.
(e) maintenance of intravenous routes using intermittent infusion devices;
Schedule 1, section 1 (e) and (f) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(e) basic wound and fracture management;
(f) maintenance of airways and ventilation.
Schedule 1, section 1 (g) to (l) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 2 (c) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(c) lifting/loading, extrication/evacuation and transportation;
Schedule 1, section 2 (d) to (i) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(d) cervical collar application and spinal immobilization on a long spine board;
(e) blood pressure assessment by auscultation and palpation;
(f) emergency fracture management/immobilization;
(g) oropharyngeal airway suctioning;
(h) oxygen administration and equipment;
(i) administration of semi-automatic or automatic external defibrillator;
Schedule 1, section 3 (b) (part) and (d) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(b) administration of the following intravenous, oral, sublingual, subcutaneous, inhaled, intra-muscular or nebulized medications:
(d) maintenance of intravenous lines using intermittent infusion devices, including saline locks and IV pumps.
Schedule 1, section 3 (b) (i) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 3 (b) (ii) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 3 (b) (vii) and (e) to (g) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 4 (b) and (g) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(b) electrocardiogram interpretation, cardioversion, external pacing and manual defibrillation;
(g) cricothyrotomy and needle thoracentesis;
Schedule 1, section 4 (c) and (k) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(c) initiation and maintenance of intraosseous needle cannulation;
(k) use and interpretation of end tidal CO2 monitoring devices;
Schedule 1, section 4 (m) (v) to (vii) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 4 (n) and (o) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 5 (d) to (i) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 6 (b) and (c) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(b) pediatric and neonatal electrocardiogram interpretation and manual defibrillation;
Schedule 1, section 6 (d) (iv) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
Schedule 1, section 6 (l) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(l) administration of drug therapy on the direct order of a medical practitioner who is designated by an employer as a Transport Advisor.
Schedule 1, section 3 (b) (viii) was added by BC Reg 243/224, effective July 23, 2024.
Schedule 1, section 6 paragraphs (m) to (u) were added by BC Reg 243/224, effective July 23, 2024.
Schedule 2, sections 1 to 4 BEFORE amended by BC Reg 144/2013, effective April 1, 2013.
EMA FR
1 If an EMA holds a licence in the category EMA FR, the board may endorse the licence to permit the EMA to provide one or more of the following services:
(a) use of airway management techniques including oropharyngeal airways, oral suction devices and oxygen-supplemented mask devices to assist ventilation;
(b) use of an automatic or semi-automatic external defibrillator;
(c) cervical collar application and spinal immobilization on a long spine board;
(d) administration of oxygen;
(e) administration of oral glucose;
(f) emergency childbirth;
(g) ventilation using pocket mask and bag/valve/mask devices.
EMR
2 If an EMA holds a licence in the category EMR, the board may endorse the licence to permit the EMA to provide one or more of the following services:
(a) maintenance of intravenous lines without medications or blood products while transporting persons between health facilities;
(b) use and interpretation of a pulse oximeter;
(c) administration of the following oral, sublingual or inhaled medications:
(i) anti-anginal;
(ii) anti-hypoglycemic agent;
(iii) analgesia;
(iv) platelet inhibitors;
(d) use and interpretation of a glucometer;
(e) chest auscultation;
(f) insertion and maintenance of nasopharyngeal airway.
PCP
3 If an EMA holds a licence in the category PCP, the board may endorse the licence to permit the EMA to provide one or more of the following services:
(a) initiation of peripheral intravenous lines;
(b) administration of the following intravenous fluids and medications:
(i) anti-hypoglycemic agent;
(ii) isotonic crystalloid solutions;
(iii) vitamin B1;
(c) endotracheal intubation.
ACP
4 If an EMA holds a licence in the category ACP, the board may endorse the licence to permit the EMA to provide one or more of the following services:
(a) mechanical ventilation;
(b) administration of drug therapy on the direct order of a medical practitioner who is designated by an employer as a Transport Advisor;
(c) urinary catheterization;
(d) arterial line management and central venous pressure monitoring;
(e) infusion of blood products;
(f) point of care testing using capillary, venous or arterial sampling;
(g) collection of arterial and venous blood samples;
(h) interpreting laboratory and radiologic data;
(i) performing and interpreting 12 lead electrocardiograph;
(j) chest tube management;
(k) central line management;
(l) management of parenteral feeding lines and equipment;
(m) provision of trans-venous pacing.
Schedule 2, section 3 (b) BEFORE amended by BC Reg 76/2014, effective May 1, 2014.
(b) administration of the following intravenous fluids and medications:
(ii) isotonic crystalloid solutions;
Schedule 2, section 3 (d) to (f) were added by BC Reg 76/2014, effective May 1, 2014.
Schedule 2, section 4 (i) before repealed by BC Reg 76/2014, effective May 1, 2014.
Schedule 2, section 1 (a), (b), (d) and (g) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(a) use of airway management techniques including oropharyngeal airways, oral suction devices and oxygen-supplemented mask devices to assist ventilation;
(b) use of an automatic or semi-automatic external defibrillator;
(g) ventilation using pocket mask and bag/valve/mask devices.
Schedule 2, section 1 (c) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(c) cervical collar application and spinal immobilization on a long spine board;
Schedule 2, section 1 (h) to (q) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 2 (a) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(a) maintenance of intravenous lines without medications or blood products while transporting persons between health facilities;
Schedule 2, section 2 (b), (d) and (f) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(b) use and interpretation of a pulse oximeter;
(d) use and interpretation of a glucometer;
(f) insertion and maintenance of nasopharyngeal airway.
Schedule 2, section 2 (c) (ii) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 2 (c) (iii) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 2 (g) and (h) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 3 (a) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(a) initiation of peripheral intravenous lines;
Schedule 2, section 3 (f) (part) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(f) administration of the following intravenous, oral, sublingual, subcutaneous, inhaled, intra-muscular or nebulized medications:
Schedule 2, section 3 (f) (iii) to (v) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 3 (g) to (m) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 4 (a) and (g) BEFORE amended by BC Reg 194/2022, effective September 28, 2022.
(g) collection of arterial and venous blood samples;
Schedule 2, section 4 (b) and (f) BEFORE repealed by BC Reg 194/2022, effective September 28, 2022.
(b) administration of drug therapy on the direct order of a medical practitioner who is designated by an employer as a Transport Advisor;
(f) point of care testing using capillary, venous or arterial sampling;
Schedule 2, section 4 (n) to (o) were added by BC Reg 194/2022, effective September 28, 2022.
Schedule 2, section 3 (n) BEFORE amended by BC Reg 254/2024, effective August 26, 2024.
(n) administration of drug therapy during transportation between facilities
(i) after consultation with a medical practitioner who
(A) is designated by an employer as a medical oversight advisor,
(B) has attended the patient at the facility from which the patient is being transported, and
(C) has advised the EMA to administer the drug therapy, and
(ii) in accordance with the treatment plan issued by the medical practitioner.